Iridian Asset Management LLC Axsome Therapeutics, Inc. Transaction History
Iridian Asset Management LLC
- $304 Million
- Q1 2025
A detailed history of Iridian Asset Management LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Iridian Asset Management LLC holds 106,312 shares of AXSM stock, worth $10.8 Million. This represents 4.08% of its overall portfolio holdings.
Number of Shares
106,312
Previous 125,079
15.0%
Holding current value
$10.8 Million
Previous $10.6 Million
17.17%
% of portfolio
4.08%
Previous 2.95%
Shares
25 transactions
Others Institutions Holding AXSM
# of Institutions
407Shares Held
36.2MCall Options Held
751KPut Options Held
568K-
Vanguard Group Inc Valley Forge, PA3.88MShares$393 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$334 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.92MShares$296 Million5.58% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$171 Million8.66% of portfolio
-
Macquarie Group LTD Australia, C3976KShares$98.9 Million0.14% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.34B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...